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Abstract
Background: Prader-Willi syndrome (PWS) is a neurobehavioral disorder characterized by neonatal hypotonia, childhood
obesity, dysmorphic features, hypogonadism, mental retardation, and behavioral problems. Although PWS is most often caused
by a paternal interstitial deletion of a 6-Mb region of chromosome 15q11-q13, the identity of the exact protein coding or
noncoding RNAs whose deficiency produces the PWS phenotype is uncertain. There are also reports describing a PWS-like
phenotype in a subset of patients with full mutations in the FMR1 (fragile X mental retardation 1) gene. Taking advantage of the
human genome sequence, we have performed extensive sequence analysis and molecular studies for the PWS candidate region.
Results: We have characterized transcripts for the first time for two UCSC Genome Browser predicted protein-coding genes,
GOLGA8E  (golgin subfamily a, 8E) and WHDC1L1  (WAS protein homology region containing 1-like 1) and have further
characterized two previously reported genes, CYF1P1 and NIPA2; all four genes are in the region close to the proximal/
centromeric deletion breakpoint (BP1). GOLGA8E belongs to the golgin subfamily of coiled-coil proteins associated with the
Golgi apparatus. Six out of 16 golgin subfamily proteins in the human genome have been mapped in the chromosome 15q11-
q13 and 15q24-q26 regions. We have also identified more than 38 copies of GOLGA8E-like sequence in the 15q11-q14 and
15q23-q26 regions which supports the presence of a GOLGA8E-associated low copy repeat (LCR). Analysis of the 15q11-q13
region by PFGE also revealed a polymorphic region between BP1 and BP2. WHDC1L1 is a novel gene with similarity to mouse
Whdc1 (WAS protein homology region 2 domain containing 1) and human JMY protein (junction-mediating and regulatory
protein). Expression analysis of cultured human cells and brain tissues from PWS patients indicates that CYFIP1 and NIPA2 are
biallelically expressed. However, we were not able to determine the allele-specific expression pattern for GOLGA8E and
WHDC1L1 because these two genes have highly related sequences that might also be expressed.
Conclusion: We have presented an updated version of a sequence-based physical map for a complex chromosomal region, and
we raise the possibility of polymorphism in the genomic orientation of the BP1 to BP2 region. The identification of two new
proteins GOLGA8E and WHDC1L1 encoded by genes in the 15q11-q13 region may extend our understanding of the molecular
basis of PWS. In terms of copy number variation and gene organization, this is one of the most polymorphic regions of the human
genome, and perhaps the single most polymorphic region of this type.
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Background
Genomic alterations of the chromosome 15q11-q13
region are associated with two distinct genomic imprint-
ing disorders, Prader-Willi syndrome (PWS) and Angel-
man syndrome (AS) [1]. PWS is characterized by neonatal
hypotonia, childhood obesity, hypogonadism, moderate
mental retardation, and behavioral problems. The most
common molecular defect found in PWS patients is a ~6-
Mb chromosomal deletion of the 15q11-q13 region on
the paternal chromosome. Maternal uniparental disomy
(UPD) of chromosome 15, microdeletions in a regulatory
region known as the imprinting center (IC), and rare chro-
mosome translocations have also been reported for PWS
patients. It is clear from molecular studies that PWS is pri-
marily caused by deficiency of a paternally expressed gene
or genes from the 15q11-q13 region. However, it remains
uncertain as to whether the major phenotypic features are
caused by deficiency of one or more than one gene and
whether such genes might be protein coding (e.g NDN or
MAGEL2) or noncoding small nucleolar RNAs (snoRNAs)
[2-4]. A 2-Mb region extending from the centromeric
breakpoint 2 (BP2) to D15S10 was initially defined as the
PWS candidate region [5]. Attempts to narrow the candi-
date region by characterizing several rare patients with
cytogenetic abnormalities have been reported by several
investigators [6-8]. However, a consensus concerning a
narrowed critical region has not yet been reached. The
controversy may arise from the complex regulation of a
large imprinted domain as evidenced by IC mutations
that have been reported to disrupt the imprinting process
both in humans and in mice [9-17]. Alternatively, if PWS
is a contiguous gene deletion syndrome, the individual
genes may only contribute to part of the phenotype [18].
Numerous protein coding genes and non-coding tran-
scripts have been isolated from the PWS candidate region.
These include SNURF-SNRPN, NDN, MKRN3, MAGEL2,
PWRN1, PWRN2, IPW, PAR-1, PAR-4, PAR-5, C15orf2,
and multiple copies of different families of snoRNA genes
[9,19-27]. All these transcripts except PWRN2  are
expressed from the paternal chromosome with brain tis-
sue-specific imprinting of PWRN1 and C15orf2 and there-
fore were considered as legitimate PWS candidate genes.
Functional studies in mutant mice have suggested that
Ndn, Magel2, or the snoRNA genes may play a role in the
pathogenesis of PWS [2,28-30]. Lee et al. also determined
the imprinting status of 22 transcripts located centro-
meric/proximal to the IC within the PWS candidate region
based on an early version of the expressed sequence tag
(EST) map and limited human genomic sequence. Seven
of these transcripts were found to be paternally expressed
but lacked protein coding potential [31]. Chai et al. iden-
tified four protein coding genes CYFIP1, NIPA1, NIPA2,
and GCP5 in the proximal breakpoint region and estab-
lished the genomic organization of the region between
the two proximal breakpoints (BP1 and BP2) [32].
There have been multiple reports over the last decade
describing a subset of fragile X syndrome patients who
shared overlapping clinical features with PWS. These
patients were often described as Prader-Willi-like fragile X
syndrome [33-38]. The shared traits include extreme obes-
ity, dysmorphic features, mental retardation and behavior
problems. These patients have typical full mutations in
the FMR1 gene indicating that the primary defect for the
PWS-like phenotype was dysregulation of FMR1. The spe-
cificity of the PWS-like clinical features in fragile X syn-
drome patients has been debated [35].
Chromosome 15 is one of the seven human chromo-
somes with a high rate of segmental duplication [39].
Zody et al. carried out a detailed analysis of the duplica-
tion structure and history of chromosome 15 and
reported that low copy repeats (LCRs), also termed seg-
mental duplications (SDs), in chromosome 15 are largely
clustered in proximal and distal 15q [40]. There are two
breakpoints (BP1 and BP2) in the centromeric region and
a single common breakpoint (BP3) in the telomeric
region [41-46]. The remarkable consistency of the break-
points strongly indicates the presence of a hot spot for
recombination. Indeed, large genomic LCRs derived from
the duplication of the actively transcribed HERC2 gene
and its pseudogenes were identified in the BP2 and BP3
regions and are believed to contribute to a certain percent-
age of chromosomal rearrangements between 15q11 and
15q13 [18]. Recent reports suggest that HERC2-associated
LCRs also are present within the BP1 region [32,47]. In
addition, Pujana et al. have described a second cluster of
LCRs (LCR15) with golgin-like protein (GLP) genomic
sequence in the 15q11-q14, 15q24, and 15q26 regions
[48,49]. Locke et al. also characterized the genomic struc-
ture and LCRs in the pericentromeric region of chromo-
some 15 proximal to BP1 [50].
Here we report an updated version of a sequence-based
BAC contig covering the PWS candidate region based on
the analysis of the finished version of the human genome
sequence (NCBI Build 36.1), and we question whether the
orientation of the BP1 to BP2 region may be polymorphic
in the population. We provide further characterization of
four protein coding genes, CYFIP1, NIPA2, GOLGA8E, and
WHDC1L1, located at the proximal breakpoint of the
PWS candidate region. GOLGA8E and WHDC1L1 are two
protein coding genes from this region that are represented
in genome databases but not previously discussed in the
published literature. CYFIP1  and  NIPA2  have been
described [32] but we have undertaken further molecular
characterization and reported new data regarding their
gene structure and complex alternative splicing pattern. In
addition, pulsed field gel electrophoresis (PFGE) analysis
of the 15q11-q13 region has revealed a highly polymor-
phic region between BP1 and BP2 that is consistent withBMC Genomics 2008, 9:50 http://www.biomedcentral.com/1471-2164/9/50
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the presence of an abundance of copy number variants
(CNVs) in the region as detected by genome-wide array
CGH analysis [40,51].
Results
Sequence-based BAC contig covering the chromosome 
15q11-q13 PWS candidate region
In an effort to annotate the 15q11-q13 region in detail
and identify novel transcripts from the PWS candidate
region, we first constructed a sequence-based BAC contig
covering the PWS candidate region and then identified
numerous overlapping ESTs and cDNA sequences prima-
rily using bioinformatics tools. In the UCSC genome
browser (NCBI Build 36.1) [52], there are four super
genomic contigs covering the 15q11-q13 common dele-
tion interval as diagramed in Fig. 1A (GenBank:
NT_078094, NT_026446, and NT_010280). There are
four sequence gaps between these contigs as diagramed in
Fig. 1A. The exact size of these gaps is unknown but they
are likely to be small based on the previously published
data using YAC contigs [43]. The genomic size of 15q11-
q13 deduced from the sequence contigs is around 6 Mb
and is larger than the 4 Mb-extent frequently cited in the
literature based on cytogenetic analysis and physical maps
generated prior to the availability of the human genome
sequence [5,43]. To construct a BAC contig covering the
region, we first identified individual BAC clones using
known genes and sequence tag site (STS) markers [44], as
well as newly identified STS markers which were inte-
grated into the UCSC genome browser; these were used as
bait to search the NCBI High Throughput Genomic
Sequence (HTGS) database [53]. The STS map reported by
Christian et al. provided a scaffold for construction of the
BAC contig [43]. A total of 65 minimal overlapping BAC
clones were identified from a region between BP1 and the
5'-end of UBE3A, and the accession numbers of overlap-
ping BAC clones are listed in Additional file 1. The BLAST
2 program [54] was then used to confirm the sequence
overlap, and sequence identity >99.5% was considered to
be significant. Although this limit was arbitrarily set, it
was based on the estimation of the overall error rate of
sequence from the human genome sequence project [55].
LCRs might have sequences that would fall within this
degree of identity. In most regions, the contig shown in
Fig. 1C is consistent with the genome assembly displayed
in multiple databases and other reports [32,41,47]. How-
ever, the orientation of the BAC contig around BP1 is
opposite to that of the contig displayed in the UCSC
genome browser [52]. The exact orientation of this region
remains uncertain and may even be polymorphic in the
population. There are still two sequence gaps around the
BP1 region as diagramed in Fig. 1 which illustrate the dif-
ficulties involved in both experimental manipulation and
computational analysis due to the existence of highly
identical LCRs within the region.
To further confirm the map position for the individual
BAC clones assembled using bioinformatics tools, we per-
formed FISH (fluorescence in situ hybridization) experi-
ments using DNA derived from selected individual BAC
clones from the region as probes. As listed in Additional
file 1, the localization of 14 BAC clones to chromosome
15q was confirmed by FISH studies (data not shown). A
simplified version of the BAC contig with only one BAC
clone for each position is diagramed in Fig. 1C. The order
of genes displayed in UCSC/Ensembl/NCBI human
genome browsers is diagramed in Fig. 1B for reference and
comparison [52,56,57]. A much more detailed descrip-
tion of the region including the BAC contig, STS markers,
CpG islands, and the map positions of novel transcripts is
summarized in Additional file 1.
Characterization of four protein-coding genes from the 
proximal breakpoint of 15q11-q13 PWS candidate region
There are numerous ESTs mapped to this region, but most
of them are intronless and/or lack major open reading
frames (ORFs), and their significance cannot be easily
addressed because they may function as noncoding RNAs
or contain potential artifacts from cDNA production. In
order to identify protein-coding genes, only transcripts
with intron-exon structure and greater than 99% sequence
identity between the EST and the matched genomic
sequence were considered significant and are listed in
Additional file 1. Towards this goal, we have analyzed
each individual EST from this region for coding potential
by ORF analysis. Most of the ESTs were overlapping and
did not have significant coding potential, with the excep-
tion of clones [GenBank: BC063309, AK057421,
BC018097, BC048987, D38549, BC011775, AK093450,
AK093463, AK093104, AF272884, and BX537997] that
displayed ORFs greater than 120 amino acids in length.
There were no additional protein-coding genes identified
in the region between NDN and SNURF-SNRPN despite
the presence of numerous ESTs with clear intron-exon
structure. In contrast, the region around the proximal
breakpoints appears to have a high density of protein-cod-
ing genes based on our analysis using bioinformatics
tools. To rule out the possibility of artifacts in these EST
clones, we first performed expression analysis by reverse
transcription polymerase chain reaction (RT-PCR) using
RNA templates isolated from human lymphoblasts and
brain tissue. Six representative cDNA clones [Genbank:
D38549, BC011775, AF272884, BX537997, BC063309,
and BC048987] were particularly interesting because of
their clear protein-coding potential and readily detectable
expression in lymphoblasts and brain tissues by RT-PCR.
Clones D38549, AF272884, BC011775, and BX537997
were identical to four genes reported by Chai et al. which
correspond to CYFIP1, NIPA1, NIPA2, and GCP5, respec-
tively, while BC063309 and BC048987 are two protein-
coding genes from this region that are predicted genes inBMC Genomics 2008, 9:50 http://www.biomedcentral.com/1471-2164/9/50
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Sequenced BAC contig and transcriptional map of chromosome 15q11-q13 Figure 1
Sequenced BAC contig and transcriptional map of chromosome 15q11-q13. (A) Genomic super-contig. Four contigs are dia-
gramed and four gaps are shown with no data shown centromeric to BP1. The exact sizes of the gaps are currently unknown. 
(B). The order of genes in the PWS candidate region displayed in UCSC, Ensembl, and NCBI human genome browsers. # indi-
cates that WHDC1LI is only displayed in the UCSC browser but not in the Ensembl and NCBI browsers. (C) Detail of 
sequence-based BAC contig. Only one BAC representing each position is diagramed, and the scale is not proportional to 
genomic size. The size of each BAC was recorded from the current entry in Genbank and readers should refer to the database 
for the most recent information if necessary. Two sequence gaps are shown in the map as filled balck bars.
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the UCSC genome browser, but have not yet been charac-
terized in the published literature. Computational analy-
ses of EST clones AK093450, AK093104, and AK093463
predict significant ORFs, but we were not able to detect
expression in either lymphoblasts or brain tissues by RT-
PCR despite multiple attempts. We were also not able to
detect any significant conservation when the sequences
were compared to those available for multiple species,
which raised a question concerning the functional signifi-
cance of these EST transcripts. There are numerous addi-
tional ESTs within the region which show clear intron-
exon structure and perfect sequence identity with the
genomic sequence but do not contain significant ORFs,
and their biological relevance remains to be defined. This
analysis also confirmed the transcripts previously
reported [31,58], but numerous additional ESTs without
protein coding potential have since been deposited in the
databases and mapped within the interval.
We have performed further analysis for two protein cod-
ing genes CYFIP1 and NIPA2 that have been previously
reported by Chai et al. There were numerous EST and
cDNA sequences identified by database searching using
the cDNA clone D38549 encoding CYFIP1  that either
overlapped, or increased the extent of the sequence at
both the 5'- and 3'-ends and additional exons and an
elongated 3'-untranslated region (UTR) were found. Alter-
natively spliced forms were identified by sequence align-
ment between the cDNA sequence and the genomic
sequences. Further sequence analysis revealed five variant
mRNA isoforms resulting from alternative 5'-splicing of
the CFYIP1 gene that appeared to encode four different
protein isoforms by ORF analysis (Fig. 2C). Isoforms 1
and 3 potentially encode the same protein with a length
of 1253 amino acids. Isoform 2 has 1255 amino acids
which is initiated from the most upstream ATG codon but
skips exon 5. Isoforms 4 and 5 appear to be initiated from
two different promoters within introns 17 and 23, respec-
tively. These two isoforms also encode two shorter ORFs
with a length of 822 amino acids for isoform 4 and 447
amino acids for isoform 5. The mRNA transcript for iso-
form 5 has the longest 3'-UTR containing five polyade-
nylation signals (AATAAA). It is not clear how the 5'-UTR
is connected to the 3'-UTR for the different mRNA iso-
forms. Isoforms 4 and 5 appeared to have much longer 3'-
UTRs when compared to isoforms 1, 2, and 3 based on the
cDNA sequence currently deposited in the databases.
Therefore, the total length of these cDNAs appeared to be
similar to the other three isoforms despite lacking numer-
ous 5'-exons. This may explain why there is a single signal
from northern blot analysis as shown in Fig. 3A. The
expression of isoforms 4 and 5 was confirmed by RT-PCR
experiments using isoform-specific primers (data not
shown). Interestingly, similar alternative splicing for iso-
form 4 is also found in mice [GenBank: BC086625] sug-
gesting a functional significance for the alternative
splicing. Sequence alignment between the cDNA
sequence and genomic sequence indicated that CYFIP1
was comprised of 33 exons, and the pattern of alternative
splicing and intron-exon junctions is diagramed in Fig. 2C
and Additional file 2. CYFIP1  spans about 110 kb of
genomic DNA. The cDNA sequence and protein isoforms
were deposited in Genbank [AY763577–AY763580]. The
majority of the 5'-exons mapped within BAC 289D12,
and a small number of 3'-exons mapped to BAC 26F2. To
examine the tissue-specific expression pattern of the
CYFIP1  gene, northern blot analyses were performed
using a 700-bp cDNA fragment generated by RT-PCR that
corresponded to the 5'-end of the D39549 sequence.
There was a strongly hybridizing 5.5-kb transcript seen in
all tissues examined indicating that the cDNA sequence
that we assembled most likely represented the full length
of the CYFIP1  mRNA. The single band from northern
analysis may represent many different transcripts with
very similar size as revealed from computational analysis.
CYFIP1 was expressed ubiquitously in numerous tissues
examined (Fig. 3A). Similarly, we have also found five dif-
ferent splicing forms by in silico analysis that result from
alternative splicing of the 5'-UTR of the NIPA2 gene but
appear to encode the same protein based on ORF analysis.
The variant NIPA2 mRNA sequences were also deposited
in Genbank [AY732242] (Fig. 2D). An ORF with 360
amino acids was deduced from the available 2.8-kb cDNA
sequence, and NIPA2 and CYFIP1 are transcribed towards
each other but the transcriptional orientation to the
centerome could not be determined definitely because
these two genes are mapped within a very polymorphic
region discussed in detail below. The intron-exon struc-
tures were determined and tabulated in Additional file 2.
NIPA2 extends over about 30 kb of genomic DNA. The
physical distance between the stop codons of CYFIP1 and
NIPA2  is only 2.8 kb and interestingly, the 3'-UTR of
CYFIP1 isoform 5 [GenBank: AY763579] and NIPA2 over-
lap (Fig. 2A).
For EST clone BC063309, a 5.3 kb-cDNA sequence was
assembled after analysis of sequence homology with
numerous overlapping EST clones. The expression of the
transcript was confirmed by performing RT-PCR and
sequencing the resulting product (data not shown). There
are 18 exons based on the sequence alignment between
the cDNA and genomic DNA and the intron-exon struc-
ture is summarized in Table 1. ORF analysis indicated that
the cDNA BC063309 putatively encodes a protein 430
amino acids in length. The amino acid sequence is identi-
cal to the sequence of golgi autoantigen, golgin subfamily
a, 8E (GOLGA8E) deposited in the database [Genbank:
NM_001012423]. The GOLGA8E gene spans about 13 kb
of genomic DNA and the transcriptional direction could
not be determined definitely because of association withBMC Genomics 2008, 9:50 http://www.biomedcentral.com/1471-2164/9/50
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Genomic structure and alternative splicing of CYFIP1, NIPA2, GOLGA8E, and WHDC1L1 genes Figure 2
Genomic structure and alternative splicing of CYFIP1, NIPA2, GOLGA8E, and WHDC1L1 genes. (A) Physical map of CYFIP1 and 
NIPA2 genes. The two genes share a part of the 3' UTR region deduced from sequence analysis. (B) Confirmation of overlap 
between BAC 26F2 and 289D12 by Southern blot analysis. DNAs from BAC 26F2 and BAC 289D12 were digested with EcoRI 
and hybridized with a cDNA probe containing part of the CYFIP1 gene. (C) Alternative splicing and protein isoforms of CYFIP1 
gene. (D) Alternative splicing and protein isoforms of NIPA2 gene. (E). Alternative splicing and protein isoforms of GOLGA8E 
gene. (F). Alternative splicing and protein isoforms of WHDC1L1 gene.
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LCRs in the region. Expression of this gene is readily
detectable in lymphoblasts and brain tissues by both RT-
PCR (data not shown) and northern blot analysis with a
predominant 6-kb transcript and a weaker 4-kb transcript
as shown in Fig. 3I and 3J. Computational analysis also
revealed two alternatively spliced forms for GOLGA8E as
diagramed in Fig. 2E. Isoform 1 has an ORF of 430 amino
acids and isoform 2 has an ORF of 283 amino acids. We
have sequenced and confirmed part of the RT-PCR prod-
ucts and the annotated sequence for both isoforms has
been deposited in the database. Protein database search-
ing identified five other golgin subfamily genes within the
15q11-q14 and 15q24-q26 regions with identity of
amino acid sequence ranging between 48–97% (see Table
2). However, protein searching for a conserved domain
did not identify a coiled-coil domain that is believed to be
characteristic for members of the golgin subfamily despite
overall strong similarity to other golgin subfamily mem-
bers.
Using an approach similar to that described above, we
also assembled a novel 3.2-kb cDNA sequence from
cDNA clones [GenBank: BC048987/BC018097] and
numerous overlapping EST sequences. The cDNA of
BC048987 is located 140 kb distal to GOLGA8E and has
multiple alternative mRNA forms. These different mRNA
isoforms are associated with numerous ORFs, ranging in
size from 42 amino acids to 153 amino acids based on
computational analysis. The longest ORF has high simi-
larity (72%) to a portion of the mouse Whdc1 protein
(WAS protein homology region 2 domain containing 1;
GenBank: NM_001004185) and thus was named
WHDC1L1  (WAS protein homology region 2 domain
containing 1-like 1). Comparison of the cDNA and
genomic DNA sequences indicate that there are 11 exons,
and two alternatively spliced forms with ORFs > 120
amino acids were identified and characterized in detail by
sequence alignment between the cDNA and genomic
sequences. We have confirmed the expression of this tran-
script in lympoblasts by RT-PCR (data not shown) and
northern blot analysis (Fig. 3G and 3H). The intron-exon
junctions and gene structure are summarized in Table 3
and alternative isoforms are diagramed in Fig. 2F. Isoform
1 has an ORF of 131 amino acids and isoform 2 has an
ORF of 153 amino acids. We have resequenced some of
the RT-PCR products and the annotated sequences for
both isoforms were deposited in the database [Genbank:
DQ309039 and DQ309040 for isoform 1 and isoform 2,
respectively]. A protein database search revealed high
identity (92%) to the middle part of hypothetical proteins
(KIAA1971 protein, amino acids 333–446) encoded by
two human cDNA clones [GenBank: AK126887/
Northern blot analysis of gene expression for CYFIP1, NIPA2, GOLGA8E, and WHDC1L1 in human and mouse Figure 3
Northern blot analysis of gene expression for CYFIP1, NIPA2, GOLGA8E, and WHDC1L1 in human and mouse. (A and B) Hybrid-
ization of human CYFIP1 (A) and NIPA2 (B) probes to a Clonetech multiple human tissue northern blot with 2 ug poly (A+) RNA 
per lane. (D and E) Mouse northern blot analysis using total RNAs hybridized with Cyfip1(D) and Nipa2(E) probes. (G and I) 
Human northern blot analysis of RNA from cultured lymphoblasts collected for the Baylor human genome polymorphism 
project by using WHDC1L1 (G) and GOLGA8E (I) probes for hybridization. The results using a control glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) probe are shown in (C), (F), (H), and (J).
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AB075851]. The KIAA1971 protein encoded by
AK126887 is weakly similar to human JMY (junction-
mediating and regulatory protein), a p300 cofactor
involved in the regulation of the p53 response [59] and its
mouse homolog named Whdc1 (WAS protein homology
region 2 domain containing 1). Interestingly, AK126887
has been mapped to the 15q24 region while Whdc1 is
located in a region homologous to human chromosome
15q24 in the central part of mouse chromosome 7. The
possibility that the BC048987/BC018097 sequences
found in the 15q11 region are part of a processed
AK126887 pseudogene was ruled out by RT-PCR experi-
ments using primers unique to the BC018097 sequence
(data not shown).
GOLGA8E associated LCR in 15q and other chromosomal 
regions
BLASTN searching of human genome sequence databases
using the GOLGA8E  cDNA as bait revealed numerous
sequences with significant similarity across the 15q11-
q14 and 15q24-q26 regions and sequence identities range
from 91–97% at the nucleotide level as summarized in
Additional file 3. There are also additional copies of
sequence with sequence identity ranging from 50–89%
that may represent different golgin subfamily genes in the
15q region (data not shown). BLAST searching also iden-
tified 6 BAC clones from chromosome 16 [GenBank:
AC141597, AC141255, AC141254, AC141247, and
AC140902], one BAC clone from chromosome 8 [Gen-
Bank: AC132916], and one BAC clone from chromosome
18 (AC136349) with sequence identity ranging from 90–
97% compared to GOLGA8E. Careful sequence analysis
revealed that the copy at genomic location
chr15q11:20986537–20999858 bp (NCBI Build 36.1)
proximal to the CYFIP1  and  NIPA2  genes showed the
highest identity to the genomic GOLGA8E DNA sequence
providing evidence that the copy at this genomic position
is actively transcribed. The rest of the copies distributed
within the 15q11-q14, 15q24-q26, and other chromo-
somal regions are likely to be part of LCRs but the possi-
bility of additional transcribed copies in other regions or
an error in map position cannot be completely ruled out.
There are five additional golgin subfamily genes mapped
within the 15q13-q14 and 15q24-q26 regions. They are
GOLGA, GOLGA6, GOLGA8A, GOLGA8B, and GOLGA8G.
The map position and genomic location of these golgin
subfamily genes in NCBI Build 36.1 are shown in Table 2.
These results further support the initial characterization of
LCR15 by Pujana et al. suggesting the presence of a new
cluster of golgin like protein (GLP or GOLGA6) sequence-
associated LCRs in this region [48,49]. We have provided
further evidence that multiple actively transcribed golgin
subfamily genes are associated with LCRs in the 15q
region. The distribution of golgin subfamily genes associ-
ated with LCRs in the 15q11-q14 region suggests that
these LCRs may contribute to the frequent long-range
chromosomal rearrangements between the 15q11 region
and the 15q24-q26 region reported in the literature [60].
Mapping of CYFIP1, NIPA2, GOLGA8E, and 
WHDC1L1 to the proximal deletion breakpoint of the 
PWS/AS common deletion interval
Christian et al. reported that the order of several known
STS markers relative to the centromere from microsatellite
marker analysis was as follows: centromere-BP1-
AC02B45-D15S912-D15S18-D15S541-D15S542-BP2-tel-
omere [43,44]. It was suggested that the class I breakpoint
mapped centromeric to D15S541/D15S542 and the class
Table 1: Intron-exon structure of GOLAG8E
Exon Exon (bp) Intron (kb) Intron Exon Exon Intron
1 146 AGTCGC AGAAAG tggctc
2 120 1.7 tggctc TTAAAA GGAGAT tgacag
3 60 0.5 tgacag TCAGCA CTGGAG ttgtag
4 81 0.2 ttgtag AGCCCG TCTTTG ctcag
5 360 0.9 ctcag AAACAA CTAGAG ccacag'
6 85 0.1 ccacag' GTTCAA TTGAAG ccaaag
7 110 0.1 ccaaag AAGAGT GAGAGG ttacag
8 90 1.1 ttacag CAGTTC ACACAG ttgcag
9 108 0.1 ttgcag TTGAAG CAGGAG gggcag
10 88 0.2 gggcag GTTTGC AGATGG tctcag
11 257 0.4 tctcag CTGAAC GAGCTG gtccag
12 69 0.3 gtccag AACAAT GGCAAG ccttag
13 66 1.4 ccttag GAGCGC GGGAAG caacag
14 92 0.4 caacag GACACG GCCATG ctccag
15 101 0.6 ctccag AGCGGC CCATCA ccgcag
16 101 0.1 ccgcag GAAAGT ATGAAG ctccag
17 152 0.1 ctccag GTGAAG ATGGTG ccaaag
18 1200 0.1 ccaaag ATCTTTBMC Genomics 2008, 9:50 http://www.biomedcentral.com/1471-2164/9/50
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II deletion breakpoint was telomeric to D15S541/
D15S542 based on the analysis of microsatellite markers
in a large series of PWS/AS patients [44,45,61]. Sequence
alignment between STS markers and the genomic
sequence of BAC clones covering the region revealed that
BAC 289D12 (AC90764) contained D15S18, D15S541,
and  D15S542, while D15912  and A002B245 mapped
within BAC 26F2 (AC011767). In addition, D15S541 and
D15S542 were found to map within CYFIP1 intron 1. The
overlap between BAC 26F2 and BAC 289D12 revealed by
sequence analysis was confirmed by Southern blot analy-
sis using the insert of D38549 as a probe to hybridize to
genomic DNA isolated from both BAC clones and
digested with the restriction enzyme EcoRI (Fig. 2B). To
determine whether CYFIP1 and NIPA2 were deleted in
PWS/AS patients known to have large deletions of chro-
mosome 15q11-q13, we performed FISH experiments on
two PWS (PWS-1 and PWS-2) and three AS patients (AS-
1, AS-2, & AS-3) using the BAC clones (289D12 and 26F2)
where CYFIP1  and NIPA2  were identified (Fig. 4, data
from one PWS patient (I, I', J& J') and three AS patients (A
to H') are shown). These patients were known to have
large chromosomal deletions of 15q11-q13 based on pre-
vious studies. Both BAC 26F2 and BAC 289D12 were
detected as red signals on chromosome 15 when a centro-
mere-specific probe from a commercial source was
detected as a green signal. As shown in Fig. 4, only one red
signal from the BAC 289D12 probe was detected in
patient PWS-1 (I &I') and two AS patients (C & E for AS-2
and G & G' for AS-3) indicating a deletion of BAC 289D12
in these three patients who are likely to have a class I dele-
tion. Two signals for the BAC 289D12 probe were present
in patients AS-1 (A and B) and PWS-2 (data not shown)
indicating that this BAC was not deleted. This is in agree-
ment with a previous report that these patients have class
II deletions [61]. For the BAC 26F2 probe, no signal or an
extremely weak signal was visualized for patient PWS-1 (J
& J') and two AS patients (AS-2 and AS-3) (D & H); all
three patients were also deleted for BAC 289D12 by FISH.
However, a very dim red signal from BAC 26F2 was appar-
ent when images of red and green signals were analyzed
separately (F & H'). This result suggests a possibility of
partial deletion of 26F2 but the inherent limitations of
FISH as a method for quantitation should also be consid-
ered. This result suggests that BAC 26F2 was likely to map
centromeric to BAC 289D12 and BAC 26F2 was partially
deleted in the AS/PWS patients analyzed. This observation
is in agreement with the results reported by Pujana et al.
using the same probes for FISH experiments, by others
using array CGH, as well as the most recent data reported
by Markoff and Flomen [41,47,48,62]. Because it was
known from microsatellite analysis that these PWS/AS
Table 2: The genome distribution of Golgin subfamily genes in human and mouse
Table Gene symbol accession No. map position genomic location aa. Iden%
Human GOLGA8E* NM_001012423 15q11 20986537–20999858 430 100
GOLGA8A* NM_015003 15q14 32458564–32487180 460 72
GOLGA8B NM_001023567 15q14 32604594–32613203 459 72
GOLGA8G* NM_01012420 15q13 26297495–26577158 260 97
GOLGA NM_018652 15q24. 70734092–70746791 693 49
GOLGA6* NM_010103840 15q26 72149251–72161944 693 48
GOLGA1 NM_002077 9q33 126680450–126743178 767 22
GOLGA2 NM_004486 9q34 130057930–130078089 430 47
GOLGA3 AF485338 12q24 131859669–131908790 1498 22
GOLGA4* NM_002078 3p22 37259742–37383245 2230 25
GOLGA5 NM_005113 14q32 92330403–92376057 731 23
GOLGA7 NM_001002296 8p11 41467330–41487654 137 N
GOLGB1 NM_004487 3q13 122865640–122951292 3259 24
GORASP2 NM_15530 2q31 171493957–171531885 452 N
GOLGA2L1 NM_017600 1223 99074326–99091202 144 36
AF332229¶ AF332229 Yq11 24765503–24770366 184 45
Mouse Golga1 NM_029793 2qB 126680478–126740968 758 20
Golga3 NM_008146 59F 131859857–131908959 1447 25
Golga4 NM_018748 9qF3 37259816–37383239 2238 24
Golga5 NM_001033065 129E 92333536–92375541 729 25
Golga7 NM_001042484 8qA2 41467233–41487467 137 N
* Indicates multiple isoforms for this protein but only one is shown in table, # the nucleotide position is referred to UCSC browser human 
genome build 36.1 and mouse genome build 36. aa, amino acid. Iden% of AA is the percentage of identity of amino acids for each gene deduced 
from BLAST 2 program when against to GOLGA8E. The 'N' indicates no significant sequence identity. ¶AF33229 is referred as Golgi autoantigen, 
golgin subfamily a2-like protein.BMC Genomics 2008, 9:50 http://www.biomedcentral.com/1471-2164/9/50
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patients (PWS-1, AS-2, and AS-3) had class I deletions, we
used the D38549 and NIPA2 inserts as probes to hybridize
to DNA from these patients for Southern blot analysis.
The dosage effect due to the deletion was revealed from
genomic DNA Southern analysis but no abnormal junc-
tion fragments were detected (data not shown) indicating
that the breakpoint is less likely to be within the CYFIP1
gene. The difficulty in identifying unique genomic probes
from the breakpoint region precluded additional analysis
such as multiple color interphase FISH to delineate the
order of BAC clones within the BP1 region.
Imprinting analysis for CYFIP1 and NIPA2
To examine whether imprinted expression is associated
with CYFIP1 and NIPA2, RNA from cultured lymphob-
lasts derived from PWS patients with class I and class II
deletions was used as a template for RT-PCR analysis. The
expression of GOLGA8E  and  WHDC1L1  was also
included in the analysis, but we were aware that it is prob-
ably impossible to determine the imprinting status for
GOLGA8E and WHDC1LI in humans because of the pres-
ence of highly similar copies of these two genes within the
region of 15q. The expression of CYFIP1,  NIPA2,
GOLGA8E, and WHDC1L1 was readily detectable in cul-
tured lymphoblasts from PWS class I and II patients by
RT-PCR analysis (data not shown). To further examine the
possibility of quantitative or leaky imprinted expression
for CYFIP1, NIPA2, GOLGA8E, and WHDC1L1, we also
used total RNA derived from lymphoblasts from PWS
patients with class I or class II deletions, and from normal
control individuals for northern blot analysis. As shown
in Fig. 5A and 5H, there was no significant difference in
expression between patients with paternal deletions and
normal controls for CYFIP1, NIPA2,  GOLGA8E, and
WHDC1L1. The decreased expression of CYFIP1 in class I
deletion patients when compared to class II deletion
patients is consistent with the conclusion that expression
is not subject to imprinting. We then attempted to exam-
ine whether CYFIP1, NIPA2, GOLGA8E, and WHDC1L1
display a tissue-specific imprinting pattern particularly in
brain as reported for other genes in the 15q11-q13 region
including UBE3A and ATP10A [63-65]. We have obtained
two brain tissues (PWS-1 and PWS-2) from the University
of Maryland brain bank from individuals for whom a PWS
diagnosis was initially made based on the clinical descrip-
tion. Molecular studies on these two cases were performed
in the lab after we obtained the tissues. Both cases have
abnormal DNA methylation at the NotI site within the
SNRPN CpG island by genomic DNA Southern blot anal-
ysis (data not shown) which supports the clinical diagno-
sis of PWS [9]. In addition, array CGH analysis revealed a
class II deletion in the case of PWS-1 but no apparent dele-
tion of 15q11-q13 was detected in the case of PWS-2
which supports the possibility of maternal UPD of chro-
mosome 15 or a rare imprinting mutation in the case of
PWS-2 (T. Sahoo, personal communication). A similar
conclusion was also reported by others [66]. We first
examined the expression of SNRPN in these two patients
as shown in Fig. 5K. The results of these experiments indi-
cated that the SNRPN transcript was not detectable by RT-
PCR which is consistent with the abnormal DNA methyl-
ation found at the SNRPN CpG island and again supports
the diagnosis of PWS. We then examined the expression of
CYFIP1, NIPA2, GOLGA8E, and WHDC1L1 in these two
patients and transcripts from these four genes were
detected by RT-PCR as shown in Fig. 5I, J, M, and 5N. The
reduced intensity of the CYFIP1  PCR products in case
PWS-2 may reflect the quality of the RNAs isolated from
archival tissues. Analysis of gene expression by northern
blot analysis in brain tissues was attempted but was not
successful due to the poor quality of the RNA isolated
from autopsy brain tissues. We have also examined the
expression of CYFIP1, NIPA2, GOLGA8E, and WHDC1L1
using RNAs derived from lymphoblast cell lines from AS
patients with a class I deletion and no evidence of allele-
specific expression was found (data not shown). These
data together with the results from deletion analysis sup-
port the conclusion that CYFIP1 and NIPA2 are not sub-
ject to imprinting in cultured lymphoblasts and brain
tissues. These results are in agreement with those reported
Table 3: Intron-exon structure of WHDC1L1
Exon Exon (bp) Intron (kb) Intron Exon Exon Intron
1 656 CCGGAC CTACAC gtaagc
2 157 2.5 ctctag GTTATT CTTTAT gtaagc
3 151 3.3 ctgtag AAGTCC TAGCAG gtaata
4 159 0.7 tggcag GAGTTT AACTAG gtgaga
5 170 0.2 taacag GAATGC GGAAAG gtaaga
6 166 1.5 aataag ATGGAA TAAAAG gtaaag
7 110 2.2 tttcag ATGAAA AACATG gtatgt
8 187 1.3 ttttag AAAAAC AGAGAG gtgggt
9 87 2.7 caccag GATCAG CAGATG gtgagt
10 89 0.3 atatag AAAAGA AAAGAT gtaagt
11 1694 2.5 ttaaag AGAAAT UTRBMC Genomics 2008, 9:50 http://www.biomedcentral.com/1471-2164/9/50
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FISH analysis of PWS/AS patients with 15q11-q13 deletions Figure 4
FISH analysis of PWS/AS patients with 15q11-q13 deletions. The chromosome 15-specific probe was labeled in green and BAC 
clones 26F2 and 289D12 were labeled in red. For (A), (B), (C), (D), (G), (H), (I,) and (J), the green and red signals were super-
imposed, while for (E), (F), (G'), (H'), (I'), and (J'), only the red signal was analyzed. BAC clone 289D12 was used as a probe for 
the images in the left column (A, C, E, G, G', I and I'), and BAC clone 26F2 was used as a probe for the images in the right col-
umn (B, D, F, H. H', J and J'). Three AS patients (AS-1, AS-2, and AS-3) and two PWS patients (PWS-1 and PWS-2) known to 
have large deletions of the 15q11-q13 region were analyzed; data for one PWS patient (PWS-1) is shown. Hybridization results 
for patient AS-1 are shown in (A) and (B), and for patient AS-2 in panels (C), (D), (E), and (F). Hybridization results for patient 
AS-3 are shown in (G), (G'), (H), and (H'), and panels (I), (I'), (J), and (J') are for patient PWS-1. For patient AS-1 in (A) and (B), 
signals for both BAC 26F2 and BAC 289D12 were seen on both chromosomes, indicating that the deletion is likely to be a 
class II deletion in this patient. For patient AS-2, the signals were absent for both BAC 26F2 and BAC 289D12 on one chromo-
some 15 as seen in (C) and (D), but a very dim red signal was seen for BAC 26F2 in one chromosome (F) when the red signal 
was analyzed separately which supports a partial deletion of 26F2 in these patients. Similar results were also seen for patients 
AS-3(G, G', H, and H') and PWS-1 (I, I', J and J').BMC Genomics 2008, 9:50 http://www.biomedcentral.com/1471-2164/9/50
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by Chai et al. [32] but a more complicated imprinting pat-
tern such as cell type- or developmental stage-specific
imprinting cannot be completely ruled out. Because of the
presence of highly homologous sequences for GOLGA8E
and WHDC1L1 in the 15q region, we were not able to
determine whether GOLGA8E  and  WHDC1L1  have
imprinted or biallelic expression.
DNA methylation of CpG islands of CYFIP1 and NIPA2
Allele-specific differential methylation has been found
consistently for multiple loci within the 15q11-q13
region where the paternal allele was usually unmethylated
while the maternal allele was methylated. As described in
the previous section, CYFIP1  and  NIPA2  are localized
within the common deletion interval described for PWS/
AS patients but most likely lie at the most centromeric end
of an imprinted domain within 15q11-q13. We have
identified typical CpG islands in the 5'-region of the
CYFIP1, NIPA2, GOLGA8E, and WHDC1L1 genes by com-
putational analysis, and a detailed map of methylation-
sensitive restriction enzyme sites was deduced (data not
shown). To examine whether allele-specific differential
DNA methylation was associated with the CYF1P1 CpG
island, a DNA probe generated by PCR amplification of
genomic DNA was used for Southern blot analysis after
digestion with BssHII in combination with HindIII. No
allele-specific methylation was found after digestion of
genomic DNA derived from any tissues examined, includ-
ing several sub-regions of the brain and various cell lines,
and both alleles appear to be completely unmethylated
(data not shown). A similar result was also obtained for
the NIPA2 CpG island where both alleles are also unmeth-
ylated (data not shown). However, we were not able to
generate unique probes for genomic DNA Southern anal-
ysis for the GOLGA8E  and  WHDC1L1  CpG islands
because of associated LCRs in the region.
Pulse Field Gel Electrophoresis (PFGE) analysis of 15q11-
q13 region
The difficulty of generating unique probes for FISH analy-
sis in the BP1 region prompted us to perform PFGE anal-
ysis to delineate the genomic structure for the BP1 region.
A total of 15 NotI sites were identified between the BP1
and BP3 regions by computational analysis. The distribu-
tion of these NotI sites, the known genes associated with
the NotI sites, and the BAC clones containing these NotI
sites are diagramed in Fig. 6A. We then performed PFGE
analysis using NotI and 5 different genomic probes gener-
ated from the 15q11-q13 region. The map position of 5
genomic probes is diagramed in Fig. 6A. These genomic
probes except P2 were generated by PCR amplification
from genomic DNAs and are located close to the CpG
island of CYFIP1 (P1), the 3'-end of the UBE3A gene (P3),
the CpG island of ATP10A (P4), and the CpG island of the
P locus for albinism. The P2 probe is a previously reported
cDNA clone named DN34 which represents part of the
MKRN3 cDNA sequence (a gift from Dr. Daniel Driscoll).
The  NotI sites associated with the SNURF-SNRPN  and
Imprinting analysis of CYFIP1, NIPA2, GOLGA8E, and  WHDC1L1 Figure 5
Imprinting analysis of CYFIP1, NIPA2, GOLGA8E, and 
WHDC1L1. Northern blot analysis of CYFIP1 and NIPA2 in 
PWS class I and class II deletion patients using cultured lym-
phoblasts. The expression of CYFIP1(A)and NIPA2 (C) was 
comparable in the normal control and class II (CII) patient 
but lower in the class I (CI) patient which is consistent with 
haplodeficiency of CYFIPI in class I patients suggesting these 
two genes are not subject to imprinting. The expression of 
WHDC1L1 in (E), and GOLGA8E in (G) is also comparable to 
the normal control but the interpretation for WHDC1L1 and 
GOLGA8E related to imprinting is complicated by the pres-
ence of many highly similar copies in the 15q region (see text 
for detailed discussion). The results using a control GAPDH 
probe are shown in (B), (D), (F), and (H). RT-PCR expres-
sion analysis of the brain tissues from PWS patients is shown 
for CYFIP1 in (I), for NIPA2 in (J), for WHDC1L1 in (M), and 
for GOLGA8E in (N). Both transcripts were detectable in 
both patients but appear to be lower in PWS-2. The absence 
of SNRPN expression in both PWS cases is confirmed in (K) 
and (L) is a GADPH control for RNA input. The "+" indicates 
a PCR reaction carried out with reverse transcriptase and "-" 
is without reverse transciptase. The molecular defect of 
PWS-2 is most consistent with maternal UPD of chromo-
some 15 or a rare possibility of an imprinting mutation 
because of the maternal methylation pattern at the SNRPN 
CpG island, the absence of expression of SNRPN, and the fail-
ure to detect a deletion by array CGH (data not shown). 
This data is also consistent with a report by others [66].BMC Genomics 2008, 9:50 http://www.biomedcentral.com/1471-2164/9/50
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MKRN3 CpG islands are known to be differentially meth-
ylated with the paternal allele unmethylated and the
maternal allele methylated [9,24]. The NotI site associated
with C15orf 2 (N6) was reported to be methylated on both
alleles with a possibility of tissue-specific differences
[23,27]. In contrast, the NotI sites associated with the
UBE3A CpG island have been previously reported to be
unmethylated for both alleles [67]. The results of the
PFGE analysis using these probes are shown in Fig. 6B and
6C. The patterns revealed by using probes from the
MKRN3 (P2) and 3'-UBE3A (P3) regions to analyze DNA
derived from PWS and AS patients with large deletions are
consistent with the results reported in the literature indi-
cating differential methylation of NotI sites (N5 and N7–
N9 in Fig. 6A) in these regions (Fig. 6B2–3) in which the
paternal allele is unmethylated and the maternal allele is
methylated [9,68,69]. The lower band shown in Fig. 6B3
represents the genomic fragment (~500 kb) from the
paternal chromosome between the SNRPN CpG island
and the UBE3A CpG island. The appearance of two closely
migrating bands in the PWS sample when hybridized with
the P2 probe suggests the presence of a genomic copy
number variant proximal to MKRN3 and probably within
the BP2 region (Fig. 6B2). A faint band in one of the AS
samples may suggest a similar copy number variant or the
possibility of incomplete restriction enzyme digestion.
We have analyzed DNA from more than 20 anonymous
normal individuals collected as part of the polymorphism
project at Baylor, and representative data are shown in Fig.
6C1–5. There is no significant variation revealed using the
P3, P4, and P5 probes in these individuals examined.
However, extensive variation was revealed by using
probes P1 and P2 among normal individuals. The pattern
revealed by the P5 probe is somewhat surprising because
of the known HERC2-associated LCR in the region. We
were not able to discern the pattern and identity of each
band by PFGE analysis because of the inability to generate
a detailed physical map for the region due to the sequence
gaps and the presence of the extensive LCRs in the region.
Further analysis using different restriction enzymes and
additional probes may help to delineate the genomic
structure of the region but will still be challenging due to
the presence of LCRs.
CYFIP1, NIPA2, and GOLGA8E are members of different 
protein families
The functions of CYFIP1,  NIPA2,  GOLGA8E, and
WHDC1L1  in mammals are unknown. To determine
whether the CYFIP1 and NIPA2 proteins contain any
functionally relevant or conserved protein motifs or
domains, we carried out protein database searching
(BLASTP) and protein motif and structural analysis
(RPSBLAST) [70]. No conserved domain or motif was
identified from this analysis. However, the protein struc-
tural analysis did reveal the presence of 5 and 8 trans-
membrane domains, respectively, for CYF1P1 and NIPA2.
To examine the cross-species conservation for the CYFIP1
and NIPA2 proteins, the cDNA sequences and their pre-
dicted amino acid sequences were compared to multiple
nucleotide and protein databases using the BLASTN and
BLASTP programs [71]. Multiple significant sequence
matches from other spcies including mouse, Drosophila, C.
elegans, pig, Fugu, Arabidopsis, and Anopheles gambiae were
identified and are diagramed in Additional file 4 for
CYFIP1 and NIPA2, respectively. A human protein PIR121
was also identified that shows high similarity to CYFIP1
and was named CYFIP2 [72]. In addition, a variety of
hypothetical proteins from C. elegans,  Drosophila, and
many other species were also identified for CYFIP2.
GOLGA8E has significant similarity to many golgin sub-
families at the nucleotide and amino acid levels (Table 2).
However, the protein structural analysis did not reveal a
characteristic coiled-coil domain for GOLGA8E. There are
total of 16 golgin subfamily genes found in the human
genome and 6 of them are mapped to the proximal 15q
region (Table 2). GOLGA8E has much higher similarity to
the subfamily mapped in the 15q region than other sub-
family genes in other chromosomal loci. In addition,
there is no immediate evidence of evolutionary conserva-
tion in the mouse and other species for GOLGA8E despite
the fact that several of its other family members appear to
be highly conserved in mice (Table 2).
Discussion
In an attempt to identify novel transcripts from the PWS
candidate region, we have constructed a sequence-based
BAC contig covering the ~2-Mb PWS candidate region.
When compared to the previously published BAC/YAC
contig covering the region of interest [32,41,44,47,73], we
believe that this version of the BAC contig contributes sig-
nificantly to the understanding of the physical map of the
15q11-q13 PWS candidate region. The current version of
the map reported here is largely consistent with the maps
reported by several other groups using the array CGH
technique [32,41,42,47]. There are two sequence gaps
remaining in the region around the proximal common
PWS/AS deletion breakpoints (BP1 and BP2) in the
sequence assembly available in the public domain. There
are still three sequence gaps within the 6-Mb region, and
closing these gaps has been challenging because of the
extremely high sequence identity between different copies
of LCRs. Makoff and Flomen recently reported closure of
these gaps by an extensive bioinformatic approach [62].
The orientation of the contig drawn from this analysis dif-
fers from the contig displayed in the UCSC genome
browser (NCBI Build 36.1) [52] in which BAC 289D12
was positioned centromeric to BAC 26F2 but is consistent
with multiple reports [41,47,62]. The apparent discrep-
ancy between the two genomic contigs may reflect an arti-
fact introduced by using computational methodologyBMC Genomics 2008, 9:50 http://www.biomedcentral.com/1471-2164/9/50
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because of the high sequence identity among the different
LCRs or other aspects of the complex genome organiza-
tion in the region. The structure depicted in the genome
browsers is an attempt to select one unique order and
copy number from data derived from two different chro-
mosomes from multiple individuals, while the chromo-
somes may have a polymorphic gene order and copy
number. This hypothesis is supported by a report that 9%
of individuals in the general population have an inversion
of the 15q11-q13 region [74], by the results from PFGE
analysis reported in this study, as well as by the array CGH
technique reported in the Database of Genomic Variants
[75]. Our experience in utilizing the human genome
sequence also emphasizes the importance of evaluating
human genome sequence data in detail for a particular
genomic region of interest before making any conclusion.
Polymorphic genomic region between BP1 and BP2 revealed by PFGE analysis Figure 6
Polymorphic genomic region between BP1 and BP2 revealed by PFGE analysis. A. A NotI restriction enzyme map of the 15q11-
q13 region revealed by computational analysis. There are total of 15 NotI sites identified and labeled as N1 to N15. N5 and 
N7–N9 were known to be differentially methylated with absence of methylation of the paternal allele and methylation of the 
maternal allele [9, 23, 68, 69] The known genes associated with NotI are diagramed below the line and the BAC clones where 
the NotI sites are mapped are shown. P1–P5 are genomic DNA probes used for PFGE analysis. B1-5. The result of PFGE analy-
sis using NotI and genomic DNA probes P1–P5. The DNAs are from PWS and AS patients with large class I deletions. The pat-
tern is consistent with allele-specific differential methylation of the NotI sites associated with SNRPN (N7-9) and MKRN3 (N5), 
methylation of both alleles for C15orf2 as previously reported, and the absence of methylation for the remainder of the NotI 
sites in the region. C1-5. The results of PFGE analysis using NotI and probes P1–P5 in normal individuals. The extensive varia-
tion revealed by probes P1 and P2 indicate a polymorphic genomic region between BP1 and BP2. The pattern of two bands 
shown in panel C3 using probe P3 is consistent with allele-specific differential DNA methylation of the NotI sites within the 
SNRPN CpG island (N7–N9). The lower band represents a genomic fragment (~500 kb) from the paternal chromosome 
between the CpG island of SNRPN and the CpG island of UBE3A.
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We have characterized transcripts for the first time for two
protein-coding genes GOLGA8E and WHDC1L1 in addi-
tion to four other genes CYFIP1, NIPA1, NIPA2, and GCP5
previously described [32] from a region close to the prox-
imal breakpoint (BP1) of the PWS candidate region. Our
results for CYFIP1 and NIPA2 are largely in agreement
with the previous report [32]. However, we have provided
additional information regarding the genomic structure,
alternative splicing, and expression pattern for both genes.
These findings would be very important for understand-
ing the function of CYFIP1 and its interaction with FMRP
and Rac1 because isoforms 4 and 5 apparently lack the N-
terminal FMRP and Rac1 interacting domain [76,77].
GOLGA8E  and  WHDC1L1  are associated with a large
number of LCRs within the 15q11-q14 and 15q24-q26
regions. The function of GOLGA8E  and  WHDC1L1  is
unknown.  GOLGA8E  belongs to the golgin subfamily
which was originally identified as a group of Golgi-local-
ized autoantigens recognized by sera from patients with a
variety of autoimmune conditions [78]. There are l6 puta-
tive golgin subfamily genes in the human genome, but
some of them have not yet been confirmed experimen-
tally. These golgin subfamily members are differentiated
mostly on the basis of molecular weight [78,79]. The
function of most of golgin subfamily genes remains
unclear, but a role for golgins in association with a GTPase
protein complex in the organization and regulation of
Golgi membrane trafficking has been suggested [80]. The
presence of 6 out 16 golgin subfamily genes in the 15q11-
q13 and 15q24-q26 regions is of interest relative to the
possibility of actively transcribed genes with LCRs and the
occurrence of LCR-mediated chromosomal rearrange-
ments in the region. The golgin subfamily genes in 15q
share higher similarity to GOLGA8E than other subfamily
members on other chromosomes. Thus, golgin subfamily
genes in 15q may have a common ancestry, and the SDs
in the region may have played a role in the formation of
new gene family members through evolution.
Although it is possible that CYFIP1and NIPA2 as well as
GOLGA8E and WHDC1L1 may all be deleted in class I
PWS patients, these four genes do not appear to be strong
candidates for a primary role in the PWS phenotype. Our
expression analysis using RNA isolated from the cultured
lymphoblasts of PWS patients carrying class I deletions
and brain tissues from patients with maternal UPD 15
suggest that CYFIP1 and NIPA2 are not subject to genomic
imprinting. The possibility of cell type or developmental
stage-specific imprinting cannot be completely ruled out
but is less likely. In addition, a possibility that the paternal
allele is more active was suggested by a recent study of the
expression profile of CYFIP1, NIPA1, NIPA2, and GCP5 in
class I and class II deletion patients using real time RT-
PCR methods, but more study is needed to make a defin-
itive conclusion [81]. It is impossible to analyze genomic
imprinting for GOLGA8E and WHDC1L1 with high confi-
dence because of multiple copies, some of which are dis-
tant from the BP1-BP2 region. Several recent reports
comparing patients with class I and class II deletions have
suggested that there are phenotypic differences between
the two groups [81-83], while another investigator did not
observe such distinctions [84]. Butler et al. recently found
that PWS patients with class I deletions have a more severe
phenotype than those with either a class II deletion or
maternal UPD using a variety of psychological and behav-
ioral tests [82]. Similarly, AS patients with class I deletions
showed complete absence of vocalization while some AS
patients with class II deletions were able to pronounce syl-
labic sounds [42,85]. These studies suggest that the dele-
tion of biallelically expressed genes located between BP1
and BP2 such as CYFIP1  may have an impact on the
degree of impairment particularly in communication and
behavior observed for both PWS and AS patients.
Mapping of the CYFIP1 gene encoding an FMRP interact-
ing protein within the PWS candidate region is of particu-
lar relevance for the analysis of the Prader-Willi-like
phenotype observed in fragile X patients with full muta-
tions in FMR1. The significance of the overlapping clinical
features between PWS and fragile X syndrome remains
uncertain, and it is very difficult to determine whether
there is any intrinsic link underlying these overlapping
clinical features solely from a clinical standpoint. Several
recent studies report that autistic spectrum disorder is
more prevalent in PWS patients than was previously
thought [86-88]. The identification of CYFIP1 in the PWS
candidate region may provide a molecular framework for
further investigation, particularly in the area of shared
autistic behavior between fragile X and Prader-Willi syn-
dromes. Indeed, alteration of CYFIP1 in PWS-like fragile X
syndrome patients was recently reported which provides a
molecular basis for the clinical observation [89]. Altered
expression of CYFIP1  has also been reported both in
autism patients with maternal duplication of 15q11-q13
and in fragile X syndrome patients with autistic features
[90].
Characterization of additional GOLGA8E  LCRs around
the BP1, BP3, and BP4 regions has added another layer of
complexity in an already complicated region. The pres-
ence of an additional LCR (LCR15) other than HERC2-
associated LCRs was first suggested by Pujana et al. [48]
with the suggestion that golgin-like sequences are associ-
ated with LCR15. With the finished version of the human
genome sequence, we were able to characterize the
genomic organization and copy number of these LCRs in
substantial detail. Like the HERC2-associated LCRs, this
new class of LCR is associated with an actively transcribed
copy of GOLGA8E. The GOLGA8E-associated LCRs have
wider genomic distribution and are found in the 15q11,BMC Genomics 2008, 9:50 http://www.biomedcentral.com/1471-2164/9/50
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q13, q24, and q26, and other chromosomal regions while
HERC2-associated LCRs are found in 15q11 and q13 and
other chromosomes [46]. The finding of GOLGA8E-asso-
ciated LCRs in the 15q11, q13, and q24-q26 regions sug-
gests that these LCRs could be responsible for longer
chromosomal rearrangements observed between the
15q11 and q24-q26 regions [60]. The degree of polymor-
phism in the BP1 and BP2 regions revealed by PFGE anal-
ysis is consistent with the data from multiple genome-
wide analyses of CNVs by array CGH displayed in the
Database of Genomic Variants or in other recent reports
[40,47,50,74]. There are 14 different genomic variants
listed in the region proximal to BP2 and most of these var-
iants are SDs, but there are two inversion variants between
BP1 and BP2, and one inversion variant between BP2 and
BP3 was previously reported [74]. Murthy et al. recently
reported a 250-kb heterozygous microdeletion covering
the CYFIP1 and NIPA1 genes in the region between BP1
and BP2 in a male patient with mental retardation [91].
The interpretation of the finding is complicated because
the same deletion was also present in the patient's father
who may have had some mild phenotypic abnormalities.
Butler et al. reported a PWS case with a typical class II dele-
tion who also had a small duplication between BP1 and
BP2, and the duplication was present in the healthy father
and his brother [92]. We have observed that BAC 289D12
in the BP1 region detects a very frequent CNV in the cases
referred for clinical array CGH analysis at Baylor College
of Medicine (Cheung and Chaw, personal communica-
tion). In most of the cases, similar duplications were also
found in one of the healthy parents and/or normal sib-
lings. Clearly this is a highly polymorphic region. Very
extensive investigations in normal individuals and in
extended family members of patients with copy number
gains or losses will be needed to determine if variations in
this region sometimes cause abnormal phenotypes. Seri-
ous genotype/phenotype analysis for this region will
require intensive copy number analysis at high resolution
such as PFGE or fiber FISH to determine not only copy
number but also orientation (regarding inversions), and
perhaps even expression and epigenetic analysis.
Conclusion
We have constructed and characterized a sequence-based
BAC contig covering the PWS candidate region using
human genome sequence databases. We have character-
ized transcripts for the first time for two protein-coding
genes, GOLGA8E (golgin subfamily a, 8E) and WHDC1L1
(WAS protein homology region containing 1-like 1) and
have further characterized two previously reported genes,
CYF1P1 and NIPA2; all four genes are in the region close
to the proximal/centromeric deletion breakpoint (BP1).
GOLGA8E belongs to the golgin subfamily of coiled-coil
domain proteins associated with the Golgi apparatus.
WHDC1L1  is a novel gene with similarity to mouse
Whdc1 (WAS protein homology region 2 domain contain-
ing 1) and human JMY protein (junction-mediating and
regulatory protein). Biallelic expression of CYFIP1  and
NIPA2 in cultured lymphoblasts and brain tissues ana-
lyzed suggests that they are unlikely to be major contribu-
tors to the pathogenesis of PWS, but haploinsufficiency
may contribute to a more prominent behavioral pheno-
type seen in PWS and Angelman syndrome (AS) patients
with class I deletions as compared to those with class II
deletions. We have also characterized a new class of
GOLGA8E-asssociated LCR in the 15q11-q13 and q24-
q26 region. This class of LCR together with HERC2-asso-
caited LCRs may contribute to the frequent chromosomal
rearrangements of 15q11-q13 and q24-q26 reported in
the literature. This is one of the most polymorphic regions
of the human genome in terms of copy number variation
and gene organization, and perhaps the single most poly-
morphic region of this type.
Methods
RNA isolation
RNA was isolated from cultured human lymphocytes and
human brain tissue, using Trizol reagent (GIBCO-BRL)
according to the manufacturer's instructions.
RT-PCR
For analysis of transcription, 3–5 ug total RNA treated
with DNaseI was used for the reverse transcription reac-
tion to synthesize single-stranded cDNA primed with ran-
dom primers (GIBCO-BRL). The subsequent PCR
reactions were performed using gene-specific primers as
listed below.
Northern analysis
Human northern blot analysis: A multiple human tissue
blot was purchased from Clonetech (BD Bioscience) and
hybridized with labeled probes following the manufac-
turer's recommendation. Mouse northern blot analysis:
For each sample, 15 ug total RNA was pretreated with
DNaseI and resolved on a 1.2% agarose gel in 10 mM
NaPO4 buffer (pH 6.8) following glyoxal/DMSO denatur-
ation using standard procedures. RNA was visualized by
ethidium bromide staining and transferred to Hybond N+
membrane (Amersham Biosciences Corp.). Hybridization
and washing conditions were the same as described below
for genomic DNA Southern analysis.
BAC DNA isolation, Genomic Southern blotting, and DNA 
methylation analysis
BAC DNA was isolated using a Qiagen Plasmid Maxi Kit
(Qiagen Inc.) with some modifications of the original
protocol. Five ug of BAC DNA was digested with EcoRI
and separated on a 0.8% agarose gel prior to transfer to
Hybond N+ membrane (Amersham Biosciences Corp.).
For DNA methylation analysis by Southern blotting,BMC Genomics 2008, 9:50 http://www.biomedcentral.com/1471-2164/9/50
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genomic DNA was first isolated from lymphoblasts by
phenol-chloroform extraction, and was then digested
with SacII and EcoRI in combination. The hybridization
buffer was prepared as described [93], and the final wash-
ing condition for the membranes was a 20 minute rinse in
a 0.2 × SSC and 1% SDS buffer.
FISH
Metaphase chromosomes were prepared using standard
protocols as described previously [94] and FISH was per-
formed as previously described [95]. BAC DNA probes
were labeled with digoxigenin and were detected by a
standard protocol. DAPI counterstain was applied, and
cells were viewed with a Zeiss Axiophot fluorescent micro-
scope (Carl Zeiss Inc.) equipped with both single-band
pass filters and a triple-band pass filter. Digital images
were captured by a Power Macintosh G3 system and Mac-
Probe version 4.0 or 4.3 (Perceptive Scientific Instru-
ments). The chromosome 15 centromere Cep (satellite
III) probe was labeled with spectrum green (Cytocell,
Rainbow Scientific).
PFGE analysis
High-molecular weight DNA was isolated and embedded
in agarose plugs from peripheral blood samples and/or
Epstein-Barr virus-transformed lymphoblastoid cells
established from patients and their parents. DNA in plugs
was digested by NotI (New England Biolabs, MA, USA).
Separation of DNA fragments was achieved using a CHEF
MAPPER (BioRAD) for 27 h with pulse time 86.54 s ramp
at 6 V/cm. After treatment with 0.25 N HCl for 30 min and
0.4 N NaOH for 40 min, gels were blotted onto a nylon
membrane. Radioactive probe labeling and hybridization
were performed using the same protocol as described for
genomic DNA Southern analysis.
PCR Primer Sequences and Conditions
The sequences of the primers used for RT-PCR analysis of
CYFIP1  were as follows: CYFIP1-2F: 5'-GTGCTGGATT-
TCTGCTACCATCTA-3' and CYFIP1-2R: 5'-GTCACAACT-
GGATTTAGTGGAAGC-3'. The cycling conditions were
denaturation at 94°C for 10 min, followed by 35 cycles of
94°C for 45 sec, annealing at 56°C for 45 sec, and exten-
sion at 72°C for 45 sec with a final 5-min extension at
72°C. The PCR product was also used for northern analy-
sis of CYFIP1 transcription. The sequences of the primers
used for generating the probe for DNA methylation anal-
ysis of the CYFIP1 CpG island were as follows using the
same cycling conditions as above: KICGF: 5'-ACAGACAC-
CTGTCTTAACGCAGGA-3' and KICGR: 5'-TCTTGGAGA-
GAGGAGTTTTGGGCT-3'. The primers used for PFGE
analysis were as follows. The P1 probe was generated
using primers KICGF and KICGR. The P3 probe was gen-
erated by amplification with primers H3F: 5'-GACTTTC-
CACCTAACTCACTCAC-3' and H3R: 5'-GCAGCTGA
GTGCCATATAATGTTG-3'. Probe P4 was generated using
primers ATPCGF: 5'-AAGTAGTCTGTGGTCTGGCCCTTG-
3' and ATPCGR: 5'-CAGACCTGGCTCAACT
GGATAACG-3'. The P5 probe was generated by amplifica-
tion with primers HP2F: 5'-TGAAATGCTCTTGCGTGGT-
TAGGA-3' and HP2R: 5'-AAATAAGGCATGCCCTCAGAG
ACA-3'. Analysis of SNRPN  expression was carried out
using the following oligonucleotides: SNRPN forward: 5'-
CACCAGGCATTAGAGGTCCAC-3' and SNRPN  reverse:
5'-GCAGAATGAGGGAACAAAAACCT-3'. The cycling con-
ditions were denaturation at 94°C for 1 min, annealing at
63°C for 1 min., and extension at 72°C for 1 min [9].
The PCR primers used for amplification of WHDC1L1
were as follows: forward: 5'-TCG GAA GTG AAA GAA CTC
AGA AGG-3'; reverse: 5'-AGA CTG AGG ATC ATT TTG
TGG AGG-3'. The PCR conditions were denaturation at
94°C for 45 sec, annealing at 63°C for 45 sec., and exten-
sion at 72°C for 1 min.
The sequences of the PCR primers used for the analysis of
GOLGA8E  were as follows: forward: 5'-AGC GTA CTA
CAG TTG GAG CAG CAA-3'; reverse: 5'-ATC TCC TTC TTC
TTG GCA GCC AAG-3'. The PCR conditions were denatur-
ation at 94°C for 45 sec, annealing at 63°C for 45 sec.,
and extension at 72°C for 45 sec.
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